Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE® in the United States
Go back to Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE® in the United States| Orexigen Therapeutics, Inc. (NASDAQ: OREX) | Delayed: 0.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.22 | 52 Week High | $4.75 | |||
| Open | $0.04 | 52 Week Low | $0.35 | |||
| Day High | $0.22 | P/E | N/A | |||
| Day Low | $0.22 | EPS | $-1.02 | |||
| Volume | 74,385 | |||||
| Takeda Pharmaceutical Co Ltd Sponsored ADR (AMEX: TKPYY) | Delayed: 16.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.59 | 52 Week High | $25.72 | |||
| Open | $37.62 | 52 Week Low | $20.32 | |||
| Day High | $16.59 | P/E | N/A | |||
| Day Low | $16.59 | EPS | $0.00 | |||
| Volume | 0 | |||||
